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1. Introduction 
The prevalence of palpable thyroid nodules in patients less than 21 years of age is only .05-
1.8% (American Cancer Society [ACS], 2009; Dinauer & Francis, 2007; Dinauer et al, 2008; 
Gosepath et al, 2007; Halac & Zimmerman, 2005, Niedziela, 2006; Ortel & Klinck 1965; 
Rallison et al 1991; Wartofsky, 2000; Wiersinga, 2007).  However, the true incidence of 
incidental nodules may be higher than 13% in the pediatric and adolescent group based on 
autopsy studies. This is in comparison to the adult population where the rate of palpable 
thyroid nodules approaches 5% with autopsy studies showing up to 70% of adults 
harboring incidental thyroid nodules (Ezzat S et al, 1994; Guth et al, 2009). Risk factors for 
the development of malignant thyroid nodules in pediatric patients include female sex, 
puberty, family history of thyroid cancer, head and neck radiation exposure, and iodine-
deficiency (Crom et al, 1997; Fleming, 1984; Fowler et al, 1989; Josephson & Zimmerman, 
2008; Samaan, 1987; Solt et al, 2001). 
Close to ten percent of all thyroid carcinomas occur in patients less than 21 years of age 
(Machens, 2010). Differentiated thyroid carcinoma (DTC) constitutes 3-8% of all childhood 
malignancies depending on the age group, and the numbers are thought to be increasing 
(ACS, 2009; Hameed & Zacharin, 2005; Hogan et al, 2009; Horner et al, 2010; Pacini, 2002; 
Ries et al, 2003; Waguespack et al, 2006). The majority of patients are adolescents between 
the ages of 15-19 with only 5% of cancers occurring in patients less than ten years of age 
(Hogan et al, 2009; Steliarova-Foucher et al, 2006). Familial thyroid carcinoma comprises 5% 
of all pediatric thyroid cancer, most commonly of the medullary subtype as part of the 
Multiple Endocrine Neoplasia 2 (MEN2) syndrome (Halac & Zimmerman, 2005; Loh, 1997; 
Nose, 2001). About 25% of pediatric thyroid nodules are malignant which is four- to five-
fold the incidence compared to adults, and up to 30-50% in strictly surgical series (Canadian 
pediatric thyroid nodule study group [Canadian], 2008; Corrias et al, 2010; Dinauer et al, 
2001; Hung, 1999; Lafferty & batch, 1997; Niedziela, 2006; Wiersinga, 2007; Yip et al, 1994).  
Patients less than 21 years of age can present with a palpable thyroid nodule discovered on 
physical examination. More recently, however, more thyroid nodules are discovered as 
incidental findings by ultrasound or other imaging studies performed for other reasons 
(Corrias et al, 2008 % 2010, Canadian, 2008). The main risk factor for thyroid malignancy in 
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these patients is a history of head and neck radiation therapy or exposure that is dose and 
age dependent, which carries a relative risk of 6-18.3 (Ceccarelli et al, 1988; Crom, 1997; 
Duffy & Fitzgerald, 1950; Faggiano, et al 2004; Gharib et al 2006;  Goepfert et al, 1984; 
Harness et al, 1992; Pacini, 2002; Sklar et al, 2000; Tucker et al, 1991; Viswanathan et al, 1994, 
Winship & Rosvoll, 1970). Other risk factors consist of a history of bone marrow transplant 
preceded by radiation therapy, family history of MEN2, Cowden’s disease, Carney’s 
complex, and Familial Adenomatous Polyposis (FAP) (Brignardello et al, 2008; Camiel et al, 
1968; Halac & Zimmerman, 2005; Smith & Kerr, 1973). 
2. Clinical evaluation 
2.1 History 
There are important questions the clinician should ask when evaluating a thyroid nodule in 
a pediatric patient. The most important risk factor for DTC is a history of head and neck 
radiation therapy or exposure (Harness, 1992). Radiation is a known risk factor for 
developing papillary thyroid cancer (PTC) (DeGroot & Paloyan, 1973; Sigurdson 1985). 
Today, many PTC patients are cancer survivors, having received internal ┛ radiation as part 
of a treatment protocol for lymphoma, especially Mantle radiation for Hodgkin’s disease 
(HD), non-Hodgkin’s lymphoma (NHL), leukemia, in preparation for a bone marrow 
transplant, or retinoblastoma. In a study of 16,500 leukemia survivors, thyroid carcinoma 
was the most common second malignancy in patients with a history of HD and NHL and 
the third most common after leukemia (Maule et al, 2007). High risk patients with thyroid 
nodules may have also received radiation forty to fifty years ago at very young ages for an 
enlarged thymus, acne, enlarged tonsils and adenoids, tinea capitis, or shoe size 
measurement (Mehta et al, 1989). Another type of high dose exposure that should be 
considered is external ┚ radiation seen secondarily from such nuclear accidents as 
Chernobyl in 1986 and Japan in 2011. As a consequence, Japanese clinicians may see an 
increase in the number of pediatric thyroid cancers in the next three to ten years. These 
cancers are exclusively of the papillary subtype, have different RET/PTC rearrangements, 
and behave somewhat differently than sporadic tumors (Demidchik et al, 2006; Dinauer et 
al, 2008;  Pacini, 2002). 
An equally important risk factor for pediatric thyroid cancer is a family history of MEN2 or 
medullary thyroid cancer (MTC). An inquiry about family history of pheochromocytoma or 
a family member that may have had an unexpected complication during an operation of an 
unknown cause should also be performed. Penetrance of MTC is 100% in patients that have 
any of the responsible genes, and all of these patients will need, at a minimum, total 
thyroidectomy with central compartment lymph node dissection.  
For solitary thyroid nodules, duration, growth and/or previous signs of infection such as 
erythema, pain or swelling are important. A thyroid nodule that varies in size over a period 
of time may be indicative of a cyst, and a thyroid cyst that has been previously drained or 
infected should make the clinician think of a thyroglossal duct cyst. The significance of 
nodular growth has been debated in the literature with some studies reporting that it is a 
risk factor for thyroid carcinoma (Canadian, 2008; Corrias et al, 2001; Degroot & Paloyan, 
1973; O’Kane, 2010). Nevertheless, a thyroid nodule that has enlarged requires further 
diagnostic evaluation.     
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For both solitary thyroid nodules and multinodular goiters, symptoms of compression, 
including shortness of breath or coughing while lying down in the supine position and/or 
dysphagia are indications for surgical resection. Additionally, one must ask about a 
permanent change in voice, which, although rare, may indicate recurrent laryngeal nerve 
compression or involvement by a thyroid cancer.   
The clinician should also inquire about symptoms of hypo- or hyperthyroidism such as 
weight loss or gain, palpitations, nervousness, excitability, or fatigue. Additionally, male 
gender itself is a risk factor for thyroid cancer, although less so in those patients less than ten 
years of age (Harach & Williams, 1985).  
2.2 Physical exam 
When evaluating any child or adolescent with thyroid nodules, a complete head and neck 
physical examination should be performed. This clinical exam entails palpating the thyroid 
gland for the presence of multiple nodules and/or diffuse glandular enlargement as well as 
the cervical lymph node basins for adenopathy. Any thyroid nodule or lymph node should 
be characterized as soft or firm, mobile or fixed, and for any tenderness to palpation. While 
soft and mobile thyroid nodules are usually associated with benignity, firm and fixed 
thyroid nodules are usually associated with malignancy. Although there is some 
controversy over whether solitary palpable nodules have an increased risk for cancer 
compared to those nodules that are discovered incidentally or part of a multinodular goiter, 
most studies in both adult and pediatric populations report similar rates of thyroid 
malignancy regardless of clinical presentation (AACE/AME, 2006; Cooper et al, 2009; 
Corrias et al, 2001; Frates et al, 2006; Gandolfi et al, 2004; Gharib, 2007; Leenhardt et al, 1999; 
Papini, 2002). Similar to nodular growth, tenderness is a finding with conflicting reports in 
the literature as to its significance in predicting thyroid cancer (Canadian, 2008; Lugo-
Vicente, 1998).  
For the rare patient with or a family history of MEN2, an examination for marfanoid 
habitus, pectus excavatum, mucosal neuromas and skin lesions should also be performed. 
3. Diagnostic procedures 
3.1 Neck ultrasound 
Neck ultrasound has become an extension of the physical exam for many clinicians. This 
imaging modality has been shown to be cost-effective and accurate in the evaluation of thyroid 
nodules in adult patients (Milas et al, 2005; Solorzano et al, 2004). Neck ultrasound provides 
information on the size, shape, and composition of thyroid nodules, evaluates the contralateral 
thyroid lobe for additional nodules, and allows the clinician to examine the cervical lymph 
node chains for suspicious adenopathy. This is especially important in the pediatric age group 
since up to 50% of these thyroid cancer patients in contemporary series present with positive 
lymph nodes (Hay et al, 2008; Hogan et al, 2009; Pacini, 2002). Since the 1980s, neck ultrasound 
has been used to evaluate thyroid nodules in pediatric and adolescent patients with a history 
of head and neck radiation therapy or exposure (Corrias et al, 2001; Crom et al, 1997; Dorzd et 
al, 2009; O’Kane, 2010; Poyhonen & Lenko, 1986; Solt et al, 2001). In the past decade, the use of 
ultrasound in guiding FNA biopsy has also led to a decreased rate of insufficient samples 
(Danese et al, 1998; Izquierdo et al, 2009, Kim MJ et al, 2008).  
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To evaluate the thyroid gland and surrounding lymph nodes, a 10-14 MHz linear array 
transducer is used. Appropriate technique entails examination of the thyroid gland and any 
nodules in both the transverse and longitudinal view, and identifying landmarks such as the 
trachea, internal jugular vein and carotid artery. Each thyroid nodule should be measured in 
three dimensions and individual characteristics documented including regular vs. irregular 
borders, solid vs. cystic architecture, hypo-, iso- or hyperechogenicity, presence of 
microcalcifications, and the presence of taller greater than wider dimensions. Cervical 
lymph nodes should similarly be evaluated for elongated vs. rounded shape, regular vs. 
irregular borders, absence of a fatty echogenic hila, heterogeneous echogenicity, 
calcifications, and irregular blood flow throughout the node vs. normal central hilar vessels.  
Although individual ultrasound characteristics are not reliable in predicting benignity or 
malignancy of thyroid nodules, certain combinations of ultrasound features do have a 
predictive value. One study demonstrated that hypoechoic thyroid nodules with irregular 
borders and microcalcifications carry a 30X risk for malignancy (Jabiev et al, 2009).  
(Figure 1) Other studies have shown similar ultrasound features predict thyroid malignancy 
in addition to intrinsic vascularity, taller greater than wider dimension (Figure 2), 
irregular halo, and elastography (Moon et al, 2011; Chan et al, 2003). Conversely, thyroid 
nodules with regular borders, cystic component, iso- or hyperechogenicity and no 
 
A 
 
B 
Fig. 1. Ultrasound features of malignant thyroid nodules. Figures 1A & B Ultrasound 
nodule characteristics include irregular borders, hypoechoic echogenicity, and 
microcalcifications 
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microcalcifications can predict benignity in patients without a history of radiation or 
thyroid cancer (Figure 3) (Goldfarb et al, 2011). In one study of pediatric patients, 
malignant thyroid nodules were more likely to have microcalcifications, 
lymphadenopathy and altered nodular vascular pattern, although each characteristic was 
only present in 47-73% of patients. Furthermore, a subset of patients deemed to have 
benign ultrasound findings, namely nodules with regular borders, normal vasculature, no 
calcifications, and no suspicious lymph nodes were followed without any change in exam 
for at least one year (Corrias et al, 2010).  
Neck ultrasound showing a hypervascular nodule in a patient with biochemical 
hyperthyroidism is consistent with a toxic thyroid nodule. On a comparable note, a diffusely 
enlarged hypervascular and hypoechoic gland, especially in a patient with ophthalmopathy 
and biochemical hyperthyroidism, is consistent with Graves’ disease. Additionally, multiple 
nodules in a hyperthyroid patient suggest a toxic multinodular goiter.  
An important component of the information obtained with ultrasound is the evaluation of 
the contralateral thyroid lobe and the surrounding lymph nodes. (Figure 4) Multiple studies 
have shown that ultrasound allows the surgeon to plan for extent of thyroidectomy 
(Mazzaglia, 2010; Papini, 2002; Park et al, 2009; Stulak et al, 2006). The authors (M.G and 
J.I.L) believe that ultrasound should be used routinely in the evaluation of thyroid nodules 
in pediatric patients with reports in the literature suggesting its advantage for this specific 
purpose (Corrias et al, 2008; Stulak et al, 2006; Wada et al, 2009). 
 
Fig. 2. Thyroid nodule with taller > wider dimensions 
 
Fig. 3. Example of thyroid nodule with benign ultrasound features 
Ultrasound nodule characteristics include regular borders, solid and cystic components, and 
no microcalcifications 
www.intechopen.com
 
Updates in the Understanding and Management of Thyroid Cancer 
 
152 
 
A 
 
B 
Fig. 4. Ultrasound features of abnormal lymph nodes 
Figure 4A &B Abnormal lymph nodes demonstrate an enlarged size, microcalcifications, 
irregular borders, and a solid component 
3.2 Scintigraphy  
Thyroid scintigraphy is mentioned mainly for historic purposes. Before ultrasound, 
radioisotope scans were utilized for evaluating thyroid nodules. “Hot” nodules were 
indicative of hyperfunctioning thyroid nodules or, if diffuse activity, Graves’ disease, and 
unlikely to be malignant. Conversely, “cold” nodules were thought to be highly suspicious 
for thyroid malignancy (Corrias et al, 2001; Scholtz et al, 2011). Aside from its inaccuracy, 
patients who undergo thyroid scintigraphy are subjected to radiation that may be of concern 
in pediatric patients. As such, there are very few, if any, indications for routine thyroid 
scintigraphy in these younger patients with thyroid nodules.  
3.3 Fine Needle Aspiration (FNA) 
Fine needle aspiration (FNA) has been extensively studied in adults. In general, FNA is a 
safe, cost-effective procedure that can be performed in the office or clinic setting. When 
positive for cancer, FNA is 90-98% sensitive for predicting thyroid cancer depending on 
institution (Tee et al, 2007). With an FNA diagnosis of malignancy, the appropriate surgical 
procedure can be performed that usually involves total thyroidectomy for all nodules 
greater than one cm, and central and/or lateral neck dissection when involved lymph nodes 
are identified either preoperatively and/or intraoperatively. In pediatric patients, however, 
there remains disagreement over the accuracy of FNA with some groups reporting high 
sensitivity and specificity whereas others suggesting the opposite; one group reported a 
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sensitivity as low as 70% (Amriki et al, 2005; Arda et al, 2001; Bargen et al, 2010; Canadian, 
2008; Corrias et al, 2001; Hosler et al, 2006; Izquierdo et al, 2009; Lugo-Vicente, 1998; 
Willgerodt et al, 2006). Additionally, “indeterminate” FNA biopsies may have up to a 50% 
chance of malignancy in multiple series with their malignant potential determined only on 
final pathology (Bargen et al, 2010; Brooks, 2001; Gharib, 2007; Kim E et al, 2003; Mandell, 
2001; Raab, 1995).  In one surgical series, benign FNA biopsy carried up to a 17% risk of 
thyroid malignancy (Tee, 2007).  
The imprecision of FNA, seemingly equal to ultrasound evaluation, becomes more 
important when considering FNA in pediatric patients. While FNA is safe and easily 
accomplished in pediatric patients, other factors should be taken into account (Willgerodt et 
al, 2006). For those patients, especially in the younger age groups, clinicians must take into 
consideration the potential inability or maturity for such patients to sit still for the 
procedure, an increased sensitivity to or fear of needle sticks, and a smaller space to 
maneuver both the ultrasound and FNA needle with precision.  
As such, the authors suggest a more selective use of FNA in pediatric patients, and 
ultrasound may be used to identify those patients who require further FNA diagnosis. The 
main role for FNA is making a definitive diagnosis of cancer in a thyroid nodule or lymph 
node with very suspicious ultrasound characteristics for preoperative planning (Lugo-
Vicente, 1998). 
FNA is performed with a 22-25 gauge needle in young adult and pediatric patients. Local 
anesthetic can be used at the discretion of the clinician. Studies have shown that multiple 
passes at different areas within the nodules as well as multiple slides give the most accurate 
biopsy results (Alexander et al, 2002). Aspirated contents should immediately be placed in 
fixative, and in an ideal setting, reviewed immediately by a cytopathologist for adequacy of 
sample. In general, thyroid nodules in the superior pole and/or anteriorly located are most 
easily biopsied in the office setting, whereas those nodules residing in a posterior location 
are more easily biopsied by interventional radiology. 
3.4 Other imaging 
In patients with a diagnosis of thyroid cancer, many advocate a preoperative chest X-ray to 
exclude for obvious pulmonary metastases (Hung, 1999; Waugepack et al, 2006). Another 
consideration is a non-contrast CT or MRI to identify pathologic lymphadenopathy or 
extensive thyroid disease preoperatively. Care must be taken not to order an intravenous 
contrast scan so as not to interfere with postoperative radioactive iodine scanning and 
treatment. 
3.5 Laboratory testing 
If not done already, laboratory evaluation should include thyroid-stimulating hormone 
(TSH) to determine if patients are euthyroid, hypothyroid or hyperthyroid. In patients that 
are suspected to have medullary thyroid carcinoma, calcitonin, CEA, and calcium levels 
should be obtained, and urine or plasma free metanephrines and normetanephrines to 
exclude underlying pheochromocytoma associated with MEN2.  
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4. Initial management 
4.1 Cystic nodules 
Whereas cystic thyroid nodules in adults are generally thought to be benign, there is some 
evidence to suggest the same does not hold true in pediatric patients (Yastovich et al, 1998). 
In adults, thyroid nodules with a cystic component can have a malignancy rate of at least 
13% (Chan et al, 2003). For purely cystic thyroid nodules with regular borders, a reasonable 
initial management approach is FNA under ultrasound guidance. The fluid should be sent 
for cytology and the patient should be monitored with serial ultrasound exam at six months 
and then yearly thereafter for three years. Although FNA may be repeated a second time, 
the patient should be advised to undergo surgical resection, usually diagnostic thyroid 
lobectomy with isthmusectomy if the thyroid cyst recurs. Thyroid lesions with mixed solid 
and cystic components should be evaluated based on a combination of ultrasound 
characteristics as outlined below.  
4.2 Toxic nodules  
Thyroid lobectomy with isthmusectomy for a solitary toxic nodule in pediatric patients is 
currently performed (Astl et al, 2004; Canadian, 2008). Although radioactive iodine therapy 
and anti-thyroid medications are efficacious in a certain percentage of patients, many 
pediatricians believe that the benefits of surgical resection outweigh the risks of receiving 
radioactive iodine therapy (RAI), the substantial rate of permanent hypothyroidism, 
noncompliance with medication, and need for immediate relief of hyperthyroid symptoms 
(school and social performance) in this particular age group (Sherman et al, 2006). 
Thyroidectomy for benign disease can be performed by an experienced thyroid surgeon 
with minimal complications (Raval et al, 2009). When only removing half of a patient’s 
thyroid gland, there is no risk of permanent hypoparathyroidism and rendering a patient 
hypothyroid is much abated. For toxic multinodular goiters, similar risks of non-surgical 
therapy apply with an even higher rate of failure for both RAI and medical therapy, as well 
as a greater chance for permanent hypothyroidism. These patients typically undergo total 
thyroidectomy due to bilateral thyroid nodules. While a risk for permanent 
hypoparathyroidism exists, the rate is very low in the hands of an experienced thyroid 
surgeon. 
4.3 Solitary thyroid nodules 
In the pediatric population, a significant number of patients will be referred for surgical 
consultation with clinical indications that necessitate thyroidectomy. These surgical 
indications include (but are not limited to) a history of head and neck radiation, history of 
MEN2, toxic nodule or multinodular goiter, obstructive symptoms, and fixed or firm 
nodule. In a pediatric patient with no evaluation, ultrasound examination should be 
performed based on the following recommendations. 
4.3.1 Benign ultrasound features 
Although large clinical studies with surgical cohorts have not been performed in the 
pediatric population, some clinicians have reported successful monitoring of pediatric 
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patients with serial ultrasound exams based on benign features alone (Corrias et al, 2010). 
Such benign thyroid nodules are iso- or hyperechoic, have regular borders, no 
microcalcifications, and no suspicious lymphadenopathy. Such nodules can be safely 
monitored with a neck ultrasound exam at six months and then yearly thereafter for three to 
five years as recommended by current ATA guidelines, or every two years by Korean 
consensus guidelines (Cooper et al, 2009; Moon et al, 2011). If thyroid nodule ultrasound 
characteristics change or new clinical factors develop that warrant surgical resection, FNA 
or diagnostic thyroid lobectomy with isthmusectomy should be considered. One long term 
study of 56 patients who were originally thought to have benign disease based on 
ultrasound and/or FNA were later found to have PTC (Ito et al, 2007). Only 5.3% of these 
patients developed recurrent disease and none died, suggesting that such thyroid cancers 
have an indolent course.   
4.3.2 Malignant ultrasound features 
Thyroid nodules that present with suspicious features such as irregular borders, 
microcalcifications, corresponding suspicious lymph nodes and hypoechogenicity may 
require surgical resection regardless of FNA results. Either diagnostic thyroid lobectomy 
with isthmusectomy and frozen section or total thyroidectomy depending on patient 
preference may be performed.  
4.3.3 Equivocal ultrasound features 
Since there are no large surgical series characterizing combinations of ultrasound features in 
the pediatric age group, nodules that have a mix of both benign and malignant features 
should be biopsied. Any FNA result other than benign should be regarded with suspicion 
since a 25% malignancy rate exists in such thyroid nodules of this pediatric age group. 
Benign FNA results in a patient with equivocal ultrasound features should at minimum 
receive close follow-up, and surgical resection should be considered for definitive diagnosis.  
For pediatric patients with FNA results, subsequent management and following 
recommendations are made. 
4.3.4 Benign FNA results 
In patients with benign FNA results, benign ultrasound features, no worrisome aspect of the 
history or physical exam, and no indication for surgical resection, thyroid nodules can be 
safely monitored with serial ultrasound exams for the next three to five years. However, 
benign FNA results may have up to a 17% false negative rate. If there are other clinical 
indications for surgical resection, such as obstructive symptoms, fixed nodule, or a history 
of head/neck radiation therapy or exposure, thyroid lobectomy with isthmusectomy should 
be performed. For benign FNA results in a thyroid nodule with suspicious ultrasound 
characteristics and no other clinical indications for surgical resection, either diagnostic 
thyroid lobectomy and isthmusectomy or close monitoring with serial ultrasound exams 
may be indicated. In such situations, the patient should be counseled that thyroid 
malignancy cannot be entirely excluded, and surgical resection may be required for 
definitive diagnosis. 
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4.3.5 Indeterminate FNA results (Bethesda III-Atypical cells and Bethesda IV-Follicular 
neoplasm 
Current ATA guidelines recommend surgical resection for any Bethesda IV follicular 
neoplasm (Cooper et al, 2009). For Bethesda III lesions, the current recommendation is 
repeat FNA. However, in pediatric patients, the next course of action should also be based 
on thyroid nodule ultrasound features and other risk factors. In the absence of any definite 
risk factors, management options include close monitoring with serial ultrasound exams if 
the nodule has benign features or diagnostic thyroid lobectomy with isthmusectomy for 
thyroid nodules with suspicious ultrasound characteristics or patient preference.  
4.3.6 Suspicious/malignant FNA results (Bethesda V and VI) 
Any thyroid nodule with an FNA diagnosis of cancer (Bethesda VI) requires surgical 
resection that usually consists of total thyroidectomy with or without neck dissection. 
Pediatric patients have a high rate of multifocality and a higher risk of recurrent disease if a 
lesser operation is performed (Cooper et al, 2009; Demidchik et al, 2006; Hay et al, 2010; 
Hung, 1999; Jarzab et al, 2000; Thompson & Hay, 2004; Welsh-Danaher et al, 1998). In 
addition, total thyroidectomy allows for the potential use of RAI therapy to treat metastatic 
disease. Total thyroidectomy also allows patients to be monitored with serum TG and TG 
antibodies for recurrent disease. Careful examination of the central and lateral neck 
compartment lymph nodes should be undertaken with preoperative ultrasound for 
potential neck dissection. Suspicious appearing lymph nodes associated with malignant 
thyroid nodules confirmed by FNA are considered cancerous until proven otherwise. Such 
suspicious lymph nodes may warrant FNA preoperatively for surgical planning or frozen 
section in the operating room.  
The sensitivity of “suspicious” or Bethesda V FNA results is somewhat institutional 
dependent. Rate of malignancy can be upward of 95% for such FNA biopsies.  If, however, 
the clinician’s respective institution has a lower rate of malignancy in Bethesda V specimens, 
an approach with diagnostic thyroid lobectomy with isthmusectomy may be undertaken. 
Frozen section may play a role in determining a definitive diagnosis of thyroid cancer in the 
operating room, allowing for total thyroidectomy at the first operation.  
4.4 Multinodular goiter  
Multiple thyroid nodules discovered on ultrasound examination in pediatric patients is 
important for surgical planning. Ultrasound features for each thyroid nodule should be 
evaluated, and further management undertaken as outlined for solitary thyroid nodules. If 
there is an indication for surgical resection for any single nodule based on risk factors, 
ultrasound features or FNA results, the presence of bilateral thyroid nodules should prompt 
consideration for total thyroidectomy. Small and less than one cm thyroid nodules with 
benign features can usually be monitored with serial ultrasound exams. An informed 
discussion should be carried out with the pediatric patient and parents.  
5. Conclusion   
Thyroid nodules in the pediatric patient require careful and vigilant evaluation. Since 
elements of a patient’s history, physical exam, or risk factors may be indications for surgical 
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resection, ultrasound should be further utilized as a key diagnostic tool to help evaluate any 
thyroid nodule in the pediatric population.  
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